Soaring Costs Push Drug Prices Up Despite Import Waivers
Story: December 24,2025
Pharmaceutical companies in Nigeria are warning that medicine prices continue to rise sharply, even after the government introduced import waivers.
Manufacturers cite high production costs, expensive logistics, and skyrocketing fuel prices as key factors driving the price surge. Industry stakeholders note that the import waiver alone is insufficient to offset the financial pressures affecting drug availability and affordability.
Consumers are feeling the impact, with essential medicines becoming increasingly costly, raising concerns over access to healthcare, especially for low-income families.
